miR-191 mediated downregulation of SATB1 has been linked to gain/loss of epithelial/mesenchymal markers in aggressive breast cancer and enhanced cell proliferation and migration in hormone dependent breast cancer (Di Leva et al., 2013; Nagpal et al., 2013). Here, SATB1 is linked to breast cancer.